Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain.

Ray WA, Chung CP, Murray KT, Hall K, Stein CM.

JAMA. 2016 Jun 14;315(22):2415-23. doi: 10.1001/jama.2016.7789.

2.

Efficacy and safety of 40 mg or 60 mg duloxetine in Japanese adults with diabetic neuropathic pain: Results from a randomized, 52-week, open-label study.

Yasuda H, Hotta N, Kasuga M, Kashiwagi A, Kawamori R, Yamada T, Baba Y, Alev L, Nakajo K.

J Diabetes Investig. 2016 Jan;7(1):100-8. doi: 10.1111/jdi.12361.

3.

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.

Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, Haanpää M, Hansson P, Jensen TS, Kamerman PR, Lund K, Moore A, Raja SN, Rice AS, Rowbotham M, Sena E, Siddall P, Smith BH, Wallace M.

Lancet Neurol. 2015 Feb;14(2):162-73. doi: 10.1016/S1474-4422(14)70251-0. Review.

4.

Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010.

Spindelegger CJ, Papageorgiou K, Grohmann R, Engel R, Greil W, Konstantinidis A, Agelink MW, Bleich S, Ruether E, Toto S, Kasper S.

Int J Neuropsychopharmacol. 2014 Oct 31;18(4). pii: pyu080. doi: 10.1093/ijnp/pyu080.

5.

Electrocardiograms changes in children with functional gastrointestinal disorders on low dose amitriptyline.

Chogle A, Saps M.

World J Gastroenterol. 2014 Aug 28;20(32):11321-5. doi: 10.3748/wjg.v20.i32.11321.

6.

Recent advances in the management of diabetic distal symmetrical polyneuropathy.

Tesfaye S.

J Diabetes Investig. 2011 Jan 24;2(1):33-42. doi: 10.1111/j.2040-1124.2010.00083.x. Review.

7.
8.

Options for treating postherpetic neuralgia in the medically complicated patient.

Bruckenthal P, Barkin RL.

Ther Clin Risk Manag. 2013;9:329-40. doi: 10.2147/TCRM.S47138.

9.

Mechanisms of drug-induced proarrhythmia in clinical practice.

Konstantopoulou A, Tsikrikas S, Asvestas D, Korantzopoulos P, Letsas KP.

World J Cardiol. 2013 Jun 26;5(6):175-85. doi: 10.4330/wjc.v5.i6.175.

10.

Disease risk score as a confounder summary method: systematic review and recommendations.

Tadrous M, Gagne JJ, Stürmer T, Cadarette SM.

Pharmacoepidemiol Drug Saf. 2013 Feb;22(2):122-9. doi: 10.1002/pds.3377. Review.

11.

Update on the management of diabetic polyneuropathies.

Shakher J, Stevens MJ.

Diabetes Metab Syndr Obes. 2011;4:289-305. doi: 10.2147/DMSO.S11324.

12.

Antidepressant-induced ubiquitination and degradation of the cardiac potassium channel hERG.

Dennis AT, Nassal D, Deschenes I, Thomas D, Ficker E.

J Biol Chem. 2011 Sep 30;286(39):34413-25. doi: 10.1074/jbc.M111.254367.

13.

Antidepressants and the risk of sudden cardiac death and ventricular arrhythmia.

Leonard CE, Bilker WB, Newcomb C, Kimmel SE, Hennessy S.

Pharmacoepidemiol Drug Saf. 2011 Sep;20(9):903-13. doi: 10.1002/pds.2181.

14.

Depression in vascular pathologies: the neurologist's point of view.

Moretti R, Bernobich E, Esposito F, Torre P, Antonello RM, De Angelis L, Bellini G.

Vasc Health Risk Manag. 2011;7:433-43. doi: 10.2147/VHRM.S20147.

15.
16.

Management of depression in patients with coronary heart disease: association, mechanisms, and treatment implications for depressed cardiac patients.

Wang JT, Hoffman B, Blumenthal JA.

Expert Opin Pharmacother. 2011 Jan;12(1):85-98. doi: 10.1517/14656566.2010.513701. Review.

17.

Treatment considerations for patients with neuropathic pain and other medical comorbidities.

Haanpää ML, Gourlay GK, Kent JL, Miaskowski C, Raja SN, Schmader KE, Wells CD.

Mayo Clin Proc. 2010 Mar;85(3 Suppl):S15-25. doi: 10.4065/mcp.2009.0645. Review.

18.

Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study.

Martinez C, Assimes TL, Mines D, Dell'aniello S, Suissa S.

BMJ. 2010 Feb 5;340:c249. doi: 10.1136/bmj.c249.

19.

A computer case definition for sudden cardiac death.

Chung CP, Murray KT, Stein CM, Hall K, Ray WA.

Pharmacoepidemiol Drug Saf. 2010 Jun;19(6):563-72. doi: 10.1002/pds.1888.

20.

Sudden death in patients receiving drugs tending to prolong the QT interval.

Jolly K, Gammage MD, Cheng KK, Bradburn P, Banting MV, Langman MJ.

Br J Clin Pharmacol. 2009 Nov;68(5):743-51. doi: 10.1111/j.1365-2125.2009.03496.x.

Items per page

Supplemental Content

Support Center